Autres langues Balchem Corporation

Actions

BCPC

US0576652004

Chimie de spécialité

Marché Fermé - Nasdaq 22:00:00 28/08/2026			Varia. 5j.	Varia. 1 janv.
178,44 ^USD	+0,33%		-0,66%	+16,35%

31/07	Transcript : Balchem Corporation, Q2 2026 Earnings Call, Jul 31, 2026
31/07	Balchem Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI

Autres langues

31/07	Tranche Update on Balchem Corporation's Equity Buyback Plan announced on December 10, 2025.
31/07	Balchem Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
31/07	Balchem Q2 Adjusted Earnings, Revenue Rise
31/07	Earnings Flash (BCPC) Balchem Corporation Posts Q2 Adjusted EPS $1.49 per Share, vs. FactSet Est of $1.40
31/07	Earnings Flash (BCPC) Balchem Corporation Reports Q2 Revenue $284.0M, vs. FactSet Est of $268.5M
31/07	Balchem Corporation Reports Second Quarter 2026 Financial Results
17/07	Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2026 Financial Results on July 31, 2026
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell 2000 Value Benchmark
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell 3000E Value Benchmark
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell 2000 Value-Defensive Index
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell 3000 Value Benchmark
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell Small Cap Comp Value Benchmark
29/06	Balchem Corporation(NasdaqGS:BCPC) added to Russell 2500 Value Benchmark
26/06	Balchem : to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
26/06	Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
27/05	Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
08/05	MSM for Knee Health Study: Clinical Research Supporting Knee Comfort and Quality of Life with OptiMSM®
01/05	Balchem : Announces Global Price Increase for Animal Nutrition and Health Products
30/04	Tranche Update on Balchem Corporation's Equity Buyback Plan announced on December 10, 2025.
30/04	Balchem's Shares Fall After Reporting Q1 Results
30/04	Balchem Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
30/04	Earnings Flash (BCPC) Balchem Corporation Posts Q1 Adjusted EPS $1.33 per Share, vs. FactSet Est of $1.33
30/04	Earnings Flash (BCPC) Balchem Corporation Reports Q1 Revenue $270.7M, vs. FactSet Est of $266.5M
30/04	Balchem : Reports First Quarter 2026 Financial Results
30/04	Balchem Corporation Reports First Quarter 2026 Financial Results